These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 28264577)

  • 1. [Centers for tobacco-dependent in the Czech Republic in 2016].
    Zvolská K; Králíková E
    Cas Lek Cesk; 2017; 156(1):19-23. PubMed ID: 28264577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Centres for Tobacco-Dependent in the Czech Republic in 2012: overview and economy].
    Králíková E; Kmeťová A; Felbrová V; Kulovaná S; Rameš J; Stěpánková L; Zvolská K; Skoupá J
    Cas Lek Cesk; 2014; 153(5):246-50. PubMed ID: 25370771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness of varenicline versus bupropion, nicotine-replacement therapy, and unaided cessation in Greece.
    Athanasakis K; Igoumenidis M; Karampli E; Vitsou E; Sykara G; Kyriopoulos J
    Clin Ther; 2012 Aug; 34(8):1803-14. PubMed ID: 22818870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Essential tobacco dependence medicines in 137 countries.
    Benipal S; Budhram DR; Bilimoria K; Woods H; Wang R; Persaud N
    Addiction; 2021 Jun; 116(6):1606-1609. PubMed ID: 33022824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of varenicline combined with nicotine replacement therapy vs varenicline alone for smoking cessation: a randomized clinical trial.
    Koegelenberg CF; Noor F; Bateman ED; van Zyl-Smit RN; Bruning A; O'Brien JA; Smith C; Abdool-Gaffar MS; Emanuel S; Esterhuizen TM; Irusen EM
    JAMA; 2014 Jul; 312(2):155-61. PubMed ID: 25005652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness analysis of varenicline versus existing smoking cessation strategies in Central America and the Caribbean using the BENESCO model.
    Lutz MA; Lovato P; Cuesta G
    Hosp Pract (1995); 2012 Feb; 40(1):24-34. PubMed ID: 22406880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [New tobacco dependence drug: Varenicline, partial agonist of alpha4beta2 acetylcholine-nicotine receptors].
    Králíková E
    Cas Lek Cesk; 2006; 145(11):832-4. PubMed ID: 17168413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Methods and results of smoking cessation in cancer smoker's].
    Dautzenberg B
    Bull Cancer; 2012 Nov; 99(11):1007-15. PubMed ID: 23131278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nicotine dependence and smoking cessation.
    Tan L; Tang Q; Hao W
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2009 Nov; 34(11):1049-57. PubMed ID: 19952392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost analysis of varenicline versus bupropion, nicotine replacement therapy, and unaided cessation in Nicaragua.
    Lutz MA; Lovato P; Cuesta G
    Hosp Pract (1995); 2012 Feb; 40(1):35-43. PubMed ID: 22406881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tobacco dependence, the most important cardiovascular risk factor: treatment in the Czech Republic.
    Králíková E; Kmeťová A; Štěpánková L; Zvolská K; Felbrová V; Kulovaná S; Bortlíček Z; Blaha M; Fraser K
    Physiol Res; 2014; 63(Suppl 3):S361-8. PubMed ID: 25428741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Behavioural interventions as adjuncts to pharmacotherapy for smoking cessation.
    Stead LF; Lancaster T
    Cochrane Database Syst Rev; 2012 Dec; 12():CD009670. PubMed ID: 23235680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Varenicline in the routine treatment of tobacco dependence: a pre-post comparison with nicotine replacement therapy and an evaluation in those with mental illness.
    Stapleton JA; Watson L; Spirling LI; Smith R; Milbrandt A; Ratcliffe M; Sutherland G
    Addiction; 2008 Jan; 103(1):146-54. PubMed ID: 18028247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Varenicline treatment of concurrent alcohol and nicotine dependence in schizophrenia: a randomized, placebo-controlled pilot trial.
    Meszaros ZS; Abdul-Malak Y; Dimmock JA; Wang D; Ajagbe TO; Batki SL
    J Clin Psychopharmacol; 2013 Apr; 33(2):243-7. PubMed ID: 23422399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An internet survey of use, opinions and preferences for smoking cessation medications: nicotine, varenicline, and bupropion.
    Etter JF; Schneider NG
    Nicotine Tob Res; 2013 Jan; 15(1):59-68. PubMed ID: 22529220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Which drug to be used in smoking cessation?
    Tønnesen P
    Pol Arch Med Wewn; 2008 Jun; 118(6):373-6. PubMed ID: 18619194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Smoking cessation with varenicline, a selective alpha4beta2 nicotinic receptor partial agonist: results from a 7-week, randomized, placebo- and bupropion-controlled trial with 1-year follow-up.
    Nides M; Oncken C; Gonzales D; Rennard S; Watsky EJ; Anziano R; Reeves KR
    Arch Intern Med; 2006 Aug 14-28; 166(15):1561-8. PubMed ID: 16908788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Smoking cessation treatment for COPD smokers: the role of pharmacological interventions.
    Jiménez-Ruiz CA; Fagerström KO
    Monaldi Arch Chest Dis; 2013 Mar; 79(1):27-32. PubMed ID: 23741943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effectiveness and safety of varenicline for smoking cessation].
    Christalla P; Dewenter M; El-Armouche A
    Dtsch Med Wochenschr; 2012 May; 137(18):940-4. PubMed ID: 22492478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristics and abstinence outcomes among tobacco quitline enrollees using varenicline or nicotine replacement therapy.
    Biazzo LL; Froshaug DB; Harwell TS; Beck HN; Haugland C; Campbell SL; Helgerson SD
    Nicotine Tob Res; 2010 Jun; 12(6):567-73. PubMed ID: 20378640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.